#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 52

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Small cell lung cancer limited stage

Not recruiting

Registered drug

Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Argipressin

Contact Research Centre

B-cell small lymphocytic lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drug

Study of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Adenocarcinoma gastric

Not recruiting

Registered drugNo placebo

Study of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer After Trastuzumab Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Paclitaxel

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on S65487 and Azacitidine for Adults with Untreated Acute Myeloid Leukemia Not Suitable for Intensive Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Chronic lymphocytic leukaemia+2

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Mosunetuzumab and Atezolizumab for Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Prostate cancer metastatic

Not recruiting

Registered drug

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

Registered drug

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study of PRS-344/S095012 and obinutuzumab combination for patients with solid tumors - First human trial to evaluate safety and effectiveness

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Obinutuzumab

Contact Research Centre

Mantle cell lymphoma

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Pirtobrutinib vs. Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Parkinson's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson's Disease

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.